vs
DYNAVAX TECHNOLOGIES CORP（DVAX）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
DYNAVAX TECHNOLOGIES CORP的季度营收约是Repay Holdings Corp的1.2倍（$94.9M vs $78.6M），DYNAVAX TECHNOLOGIES CORP净利率更高（28.4% vs -178.3%，领先206.7%），DYNAVAX TECHNOLOGIES CORP同比增速更快（17.7% vs 0.4%），DYNAVAX TECHNOLOGIES CORP自由现金流更多（$32.6M vs $23.2M），过去两年DYNAVAX TECHNOLOGIES CORP的营收复合增速更高（30.6% vs -1.3%）
Dynavax Technologies Corp是一家处于商业化阶段的生物制药企业，专注于研发和生产针对传染病的创新疫苗及免疫疗法，核心上市产品为成人乙肝疫苗Heplisav-B，主要市场覆盖北美与欧洲，同时拥有多款针对未满足公共卫生需求的在研产品。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
DVAX vs RPAY — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.9M | $78.6M |
| 净利润 | $26.9M | $-140.1M |
| 毛利率 | — | 74.2% |
| 营业利润率 | 22.4% | -182.2% |
| 净利率 | 28.4% | -178.3% |
| 营收同比 | 17.7% | 0.4% |
| 净利润同比 | 53.0% | -3304.1% |
| 每股收益（稀释后） | $0.21 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $78.6M | ||
| Q3 25 | $94.9M | $77.7M | ||
| Q2 25 | $95.4M | $75.6M | ||
| Q1 25 | $68.2M | $77.3M | ||
| Q4 24 | $72.0M | $78.3M | ||
| Q3 24 | $80.6M | $79.1M | ||
| Q2 24 | $73.8M | $74.9M | ||
| Q1 24 | $50.8M | $80.7M |
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $26.9M | $-6.4M | ||
| Q2 25 | $18.7M | $-102.3M | ||
| Q1 25 | $-96.1M | $-7.9M | ||
| Q4 24 | $7.0M | $-4.1M | ||
| Q3 24 | $17.6M | $3.2M | ||
| Q2 24 | $11.4M | $-4.1M | ||
| Q1 24 | $-8.7M | $-5.2M |
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
| Q4 25 | — | -182.2% | ||
| Q3 25 | 22.4% | -3.9% | ||
| Q2 25 | 15.1% | -138.7% | ||
| Q1 25 | -34.7% | -4.7% | ||
| Q4 24 | -2.3% | -1.5% | ||
| Q3 24 | 12.5% | -0.9% | ||
| Q2 24 | 7.0% | -4.6% | ||
| Q1 24 | -35.0% | -3.1% |
| Q4 25 | — | -178.3% | ||
| Q3 25 | 28.4% | -8.3% | ||
| Q2 25 | 19.6% | -135.2% | ||
| Q1 25 | -141.0% | -10.3% | ||
| Q4 24 | 9.8% | -5.3% | ||
| Q3 24 | 21.8% | 4.1% | ||
| Q2 24 | 15.4% | -5.4% | ||
| Q1 24 | -17.2% | -6.5% |
| Q4 25 | — | $-1.68 | ||
| Q3 25 | $0.21 | $-0.08 | ||
| Q2 25 | $0.14 | $-1.15 | ||
| Q1 25 | $-0.77 | $-0.09 | ||
| Q4 24 | $0.07 | $-0.04 | ||
| Q3 24 | $0.12 | $0.03 | ||
| Q2 24 | $0.08 | $-0.04 | ||
| Q1 24 | $-0.07 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $534.1M | $484.4M |
| 总资产 | $946.5M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势，按日历期对齐
| Q4 25 | — | $115.7M | ||
| Q3 25 | $160.2M | $95.7M | ||
| Q2 25 | $99.1M | $162.6M | ||
| Q1 25 | $51.7M | $165.5M | ||
| Q4 24 | $95.9M | $189.5M | ||
| Q3 24 | $119.3M | $168.7M | ||
| Q2 24 | $112.5M | $147.1M | ||
| Q1 24 | $132.0M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | — | $484.4M | ||
| Q3 25 | $534.1M | $616.9M | ||
| Q2 25 | $494.2M | $633.7M | ||
| Q1 25 | $530.9M | $755.7M | ||
| Q4 24 | $596.8M | $761.3M | ||
| Q3 24 | $681.4M | $754.7M | ||
| Q2 24 | $642.8M | $815.4M | ||
| Q1 24 | $618.5M | $813.8M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $946.5M | $1.3B | ||
| Q2 25 | $918.4M | $1.4B | ||
| Q1 25 | $945.9M | $1.5B | ||
| Q4 24 | $986.3M | $1.6B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $1.0B | $1.5B | ||
| Q1 24 | $986.6M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $23.2M |
| 自由现金流率自由现金流/营收 | 34.4% | 29.6% |
| 资本支出强度资本支出/营收 | 1.3% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.26× | — |
| 过去12个月自由现金流最近4个季度 | $80.5M | $90.7M |
8季度趋势，按日历期对齐
| Q4 25 | — | $23.3M | ||
| Q3 25 | $33.8M | $32.2M | ||
| Q2 25 | $23.4M | $33.1M | ||
| Q1 25 | $-19.6M | $2.5M | ||
| Q4 24 | $53.0M | $34.3M | ||
| Q3 24 | $19.5M | $60.1M | ||
| Q2 24 | $10.7M | $31.0M | ||
| Q1 24 | $-16.7M | $24.8M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $32.6M | $32.1M | ||
| Q2 25 | $22.0M | $33.0M | ||
| Q1 25 | $-23.6M | $2.4M | ||
| Q4 24 | $49.5M | $34.0M | ||
| Q3 24 | $18.1M | $59.8M | ||
| Q2 24 | $9.9M | $30.5M | ||
| Q1 24 | $-17.4M | $24.7M |
| Q4 25 | — | 29.6% | ||
| Q3 25 | 34.4% | 41.3% | ||
| Q2 25 | 23.0% | 43.6% | ||
| Q1 25 | -34.6% | 3.0% | ||
| Q4 24 | 68.8% | 43.5% | ||
| Q3 24 | 22.5% | 75.6% | ||
| Q2 24 | 13.5% | 40.7% | ||
| Q1 24 | -34.3% | 30.6% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 1.3% | 0.2% | ||
| Q2 25 | 1.5% | 0.1% | ||
| Q1 25 | 5.8% | 0.2% | ||
| Q4 24 | 4.8% | 0.3% | ||
| Q3 24 | 1.7% | 0.3% | ||
| Q2 24 | 1.1% | 0.6% | ||
| Q1 24 | 1.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | 18.52× | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
